Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
The Mega-Drug Development Program will invest up to $10...
China CRO Tigermed Consulting...
Hutchison MediPharma Limited sold an option on its...
WuXi PharmaTech (药明康德) reported a 5%...
Xian-Janssen launched Dacogen, a myelodysplastic syndrome...
Cheezheng Tibetan Medicine was approved to IPO on the...
Earnings season has now arrived, and China life science...
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
The world of China life science is...
IMS Health predicts China’s drug market will see a...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
